Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3526 AL 3540

Parkinson's Disease-vulnerable and -resilient dopamine neurons display opposite responses to excitatory input

Hadjas LC, Kollman GJ, Linderhof L, Xia M, Mansur S, Saint-Pierre M, Lim BK, Lee EB, Cicchetti F, Awatramani R, Hollon NG, Hnasko TS.

bioRxiv [Preprint]. 2025 Jun 7:2025.06.03.657460. doi: 10.1101/2025.06.03.657460.

Progressive vulnerability of cortical synapses in α-synucleinopathy

Sah S, Sauerbeck AD, Gupta J, Pérez-Acuña D, Reiber JE, Singh V, Russell DL, Goralski TM, Henderson MX, Volpicelli-Daley LA, Higley MJ, Kummer TT, Biederer T.

bioRxiv [Preprint]. 2025 May 31:2024.06.20.599774. doi: 10.1101/2024.06.20.599774.

The contribution of type-I IFN-mediated neuroinflammation to Parkinson's disease progression

Chen S, Crack PJ, Taylor JM.

Brain Behav Immun Health. 2025 May 21;46:101017. doi: 10.1016/j.bbih.2025.101017. eCollection 2025 Jul.

Emerging Techniques for the Identification of Traditional Chinese Medicine-Derived Molecules Targeting Parkinson's Disease

Jin Y, Yang Y, Sun Y, Mellick GD, Sun Y, Xu M.

ACS Chem Neurosci. 2025 Jul 2;16(13):2343-2354. doi: 10.1021/acschemneuro.5c00127. Epub 2025 Jun 12.

Clinical Diagnosis of Progressive Supranuclear Palsy (PSP): A Clinicopathological Comparison of Patients with Confirmed PSP and Clinical Mimics

Wrigley S, Cullinane PW, Parmera JB, Arca VM, Sifontes Valladares W, Rivera-Sánchez M, Curless T, Chajed LP, Burrows M, Revesz T, Morris HR, Jaunmuktane Z, Warner TT, de Pablo-Fernández E.

Mov Disord. 2025 Oct;40(10):2116-2128. doi: 10.1002/mds.30261. Epub 2025 Jun 12.

Changes in Gait Speed Vary Widely after the Use of Antiparkinson Medication in Persons with Parkinson's Disease

Rosenfeldt AB, Lopez-Lennon C, Suttman E, Jansen AE, Zimmerman E, Miller C, Lovati R, Fernandez HH, Imrey PB, Dibble LE, Alberts JL.

Mov Disord Clin Pract. 2025 Dec;12(12):2217-2223. doi: 10.1002/mdc3.70169. Epub 2025 Jun 12.

Sleep Stage Classification Using Subthalamic Nucleus Local Field Potentials Following Long-Term Neuromodulation in Parkinson's Disease

Zhang G, Guan L, Gao Y, Shi L, Yuan X, Zhang Y, Yin G, Yang A, Meng F, Zhang J, Yu H, Li L.

Mov Disord. 2025 Aug;40(8):1732-1734. doi: 10.1002/mds.30264. Epub 2025 Jun 12.

Neuroinflammation in chronic pain: Myth or reality?

Butler SH.

Scand J Pain. 2025 Jun 11;25(1). doi: 10.1515/sjpain-2024-0065. eCollection 2025 Jan 1.

Cognitive effects of a single dose of methylphenidate in Parkinson's disease patients using electrophysiological measures

Fogelson N, Lopez EM, Gonzalez MR, Fernandez-Del-Olmo M, Gurevich T, Desojo LV.

Clin Neurophysiol. 2025 Aug;176:2110781. doi: 10.1016/j.clinph.2025.2110781. Epub 2025 Jun 6.

Corrigendum to "Flavonoids: Their putative neurological roles, epigenetic changes, and gut microbiota alterations in Parkinson's disease" [Biomed. Pharmacother. 168 (2023) 115788]

Açar Y, Ağagündüz D, De Cicco P, Capasso R.

Biomed Pharmacother. 2025 Aug;189:118231. doi: 10.1016/j.biopha.2025.118231. Epub 2025 Jun 11.

Exercise orchestrates systemic metabolic and neuroimmune homeostasis via the brain-muscle-liver axis to slow down aging and neurodegeneration: a narrative review

Kong J, Xie Y, Fan R, Wang Q, Luo Y, Dong P.

Eur J Med Res. 2025 Jun 12;30(1):475. doi: 10.1186/s40001-025-02751-9.

Microecologics and Exercise: Targeting the Microbiota-Gut-Brain Axis for Central Nervous System Disease Intervention

Peng Z, Hou T, Yang K, Zhang J, Mao YH, Hou X.

Nutrients. 2025 May 23;17(11):1769. doi: 10.3390/nu17111769.

Actual Data on Essential Trace Elements in Parkinson's Disease

Popescu C, Munteanu C, Spînu A, Andone I, Bistriceanu R, Postoiu R, Suciu A, Giuvara S, Vlădulescu-Trandafir AI, Aurelian SM, Pop NL, Ciobanu V, Onose G.

Nutrients. 2025 May 29;17(11):1852. doi: 10.3390/nu17111852.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias